Wuwei Kushen Changrong capsule alleviates DSS-induced colitis in mice via inhibition of NLRP3 inflammasome and STAT3 pathway

• Автори: Mingjun Chen (Автор), Yang Feng (Автор), Dan Luo (Автор), Chen Zhang (Автор), Jing Zhou (Автор), Hengheng Dai (Автор), Mingxiong Lin (Автор), ZhanQi Tong (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

PurposeWuwei Kushen Changrong capsule (Composite Sophora Colon-soluble Capsule, CSCC) is a Chinese patent medicine developed to treat ulcerative colitis. Studies highlight CSCC potential efficacy for ulcerative colitis (UC) but unclear mechanism limits its widely treatment for patients. We aimed to...